FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382397027> ?p ?o ?g. }

• W4382397027 abstract "Introduction ALK tyrosine kinase inhibitors (ALK TKIs) have improved prognosis in ALK -rearranged ( ALK + ) non-small-cell lung cancer (NSCLC). However, drug resistance mechanisms occur inevitably during the course of treatment leading to disease progression. Activation of epidermal growth factor receptor (EGFR) bypass signaling pathway is an uncommon cause of acquired resistance to ALK TKIs. Method We present two patients with EML4-ALK rearranged NSCLC, developing an acquired EGFR resistance mutation after receiving multiple lines of ALK TKIs. Results While preclinical models have showed encouraging data, there is a critical need for clinical studies on treatment strategies to overcome this drug resistance. Three real-life therapeutic approaches were used in this report: i) using brigatinib, an inhibitor targeting both ALK and EGFR tyrosine kinases; ii) combining two ALK TKIs together; and iii) delivering doublet platinum chemotherapy. In case 1, time to treatment failure (TTF) was 9.5 months with brigatinib; in case 2, TTF was 10 months with combined TKIs (osimertinib and brigatinib), whereas TTF with chemotherapy was only 2 months. Tolerability profile TKIs combotherapy was acceptable. Conclusion These case reports underline the therapeutic complexity of EGFR -acquired resistance mutation in ALK + NSCLC and offers some leads to solve this real-life clinical challenge." @default.
• W4382397027 created "2023-06-29" @default.
• W4382397027 creator A5006130660 @default.
• W4382397027 creator A5010277847 @default.
• W4382397027 creator A5016000699 @default.
• W4382397027 creator A5024251845 @default.
• W4382397027 creator A5027068255 @default.
• W4382397027 creator A5032160240 @default.
• W4382397027 creator A5042298108 @default.
• W4382397027 creator A5055997556 @default.
• W4382397027 creator A5061500879 @default.
• W4382397027 date "2023-06-28" @default.
• W4382397027 modified "2023-10-18" @default.
• W4382397027 title "Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports" @default.
• W4382397027 cites W2096156234 @default.
• W4382397027 cites W2140333474 @default.
• W4382397027 cites W2219130416 @default.
• W4382397027 cites W2225691928 @default.
• W4382397027 cites W2482427906 @default.
• W4382397027 cites W2529194187 @default.
• W4382397027 cites W2533300620 @default.
• W4382397027 cites W2595645511 @default.
• W4382397027 cites W2796923356 @default.
• W4382397027 cites W2923683745 @default.
• W4382397027 cites W3020050719 @default.
• W4382397027 cites W3082768782 @default.
• W4382397027 cites W3092018851 @default.
• W4382397027 cites W3109531772 @default.
• W4382397027 cites W3121410155 @default.
• W4382397027 cites W4295297459 @default.
• W4382397027 doi "https://doi.org/10.3389/fonc.2023.1182558" @default.
• W4382397027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37448514" @default.
• W4382397027 hasPublicationYear "2023" @default.
• W4382397027 type Work @default.
• W4382397027 citedByCount "1" @default.
• W4382397027 crossrefType "journal-article" @default.
• W4382397027 hasAuthorship W4382397027A5006130660 @default.
• W4382397027 hasAuthorship W4382397027A5010277847 @default.
• W4382397027 hasAuthorship W4382397027A5016000699 @default.
• W4382397027 hasAuthorship W4382397027A5024251845 @default.
• W4382397027 hasAuthorship W4382397027A5027068255 @default.
• W4382397027 hasAuthorship W4382397027A5032160240 @default.
• W4382397027 hasAuthorship W4382397027A5042298108 @default.
• W4382397027 hasAuthorship W4382397027A5055997556 @default.
• W4382397027 hasAuthorship W4382397027A5061500879 @default.
• W4382397027 hasBestOaLocation W43823970271 @default.
• W4382397027 hasConcept C114851261 @default.
• W4382397027 hasConcept C117643217 @default.
• W4382397027 hasConcept C121608353 @default.
• W4382397027 hasConcept C126322002 @default.
• W4382397027 hasConcept C143998085 @default.
• W4382397027 hasConcept C170493617 @default.
• W4382397027 hasConcept C197934379 @default.
• W4382397027 hasConcept C2776232967 @default.
• W4382397027 hasConcept C2776256026 @default.
• W4382397027 hasConcept C2777626846 @default.
• W4382397027 hasConcept C2778087573 @default.
• W4382397027 hasConcept C2778375690 @default.
• W4382397027 hasConcept C2778820342 @default.
• W4382397027 hasConcept C2779422266 @default.
• W4382397027 hasConcept C2779438470 @default.
• W4382397027 hasConcept C42362537 @default.
• W4382397027 hasConcept C502942594 @default.
• W4382397027 hasConcept C54355233 @default.
• W4382397027 hasConcept C71924100 @default.
• W4382397027 hasConcept C86803240 @default.
• W4382397027 hasConceptScore W4382397027C114851261 @default.
• W4382397027 hasConceptScore W4382397027C117643217 @default.
• W4382397027 hasConceptScore W4382397027C121608353 @default.
• W4382397027 hasConceptScore W4382397027C126322002 @default.
• W4382397027 hasConceptScore W4382397027C143998085 @default.
• W4382397027 hasConceptScore W4382397027C170493617 @default.
• W4382397027 hasConceptScore W4382397027C197934379 @default.
• W4382397027 hasConceptScore W4382397027C2776232967 @default.
• W4382397027 hasConceptScore W4382397027C2776256026 @default.
• W4382397027 hasConceptScore W4382397027C2777626846 @default.
• W4382397027 hasConceptScore W4382397027C2778087573 @default.
• W4382397027 hasConceptScore W4382397027C2778375690 @default.
• W4382397027 hasConceptScore W4382397027C2778820342 @default.
• W4382397027 hasConceptScore W4382397027C2779422266 @default.
• W4382397027 hasConceptScore W4382397027C2779438470 @default.
• W4382397027 hasConceptScore W4382397027C42362537 @default.
• W4382397027 hasConceptScore W4382397027C502942594 @default.
• W4382397027 hasConceptScore W4382397027C54355233 @default.
• W4382397027 hasConceptScore W4382397027C71924100 @default.
• W4382397027 hasConceptScore W4382397027C86803240 @default.
• W4382397027 hasLocation W43823970271 @default.
• W4382397027 hasLocation W43823970272 @default.
• W4382397027 hasLocation W43823970273 @default.
• W4382397027 hasOpenAccess W4382397027 @default.
• W4382397027 hasPrimaryLocation W43823970271 @default.
• W4382397027 hasRelatedWork W1889913689 @default.
• W4382397027 hasRelatedWork W2042683997 @default.
• W4382397027 hasRelatedWork W2503069423 @default.
• W4382397027 hasRelatedWork W2542474044 @default.
• W4382397027 hasRelatedWork W2546236621 @default.
• W4382397027 hasRelatedWork W3137415510 @default.
• W4382397027 hasRelatedWork W3152767218 @default.
• W4382397027 hasRelatedWork W4293104804 @default.
• W4382397027 hasRelatedWork W4313879947 @default.

• next